65 related articles for article (PubMed ID: 15318708)
1. [Effect of light deprivation on homeostasis, life span and development of spontaneous tumors in HER-2/neu transgenic mice].
Baturin DA; Alimova IN; Popovich IG; Zabezhinskiĭ MA; Semenchenko AV; Iashin AI; Anisimov VN
Vopr Onkol; 2004; 50(3):332-8. PubMed ID: 15318708
[TBL] [Abstract][Full Text] [Related]
2. The effect of light regimen and melatonin on the development of spontaneous mammary tumors in HER-2/neu transgenic mice is related to a downregulation of HER-2/neu gene expression.
Baturin DA; Alimova IN; Anisimov VN; Popovich IG; Zabezhinski MA; Provinciali M; Mancini R; Franceschi C
Neuro Endocrinol Lett; 2001 Dec; 22(6):441-7. PubMed ID: 11781542
[TBL] [Abstract][Full Text] [Related]
3. Body weight is not always a good predictor of longevity in mice.
Anisimov VN; Arbeev KG; Popovich IG; Zabezhinksi MA; Rosenfeld SV; Piskunova TS; Arbeeva LS; Semenchenko AV; Yashin AI
Exp Gerontol; 2004 Mar; 39(3):305-19. PubMed ID: 15036390
[TBL] [Abstract][Full Text] [Related]
4. [The effects of Celebrex on mammary tumorigenesis and aging in HER2/neu transgenic mice].
Piskunova TS; Suspitsin EN; Sokolenko AP; Zabezhinskiĭ MA; Imianitov EI; Semenchenko AV; Anisimov VN
Vopr Onkol; 2009; 55(1):89-92. PubMed ID: 19435207
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
Anisimov VN; Berstein LM; Egormin PA; Piskunova TS; Popovich IG; Zabezhinski MA; Kovalenko IG; Poroshina TE; Semenchenko AV; Provinciali M; Re F; Franceschi C
Exp Gerontol; 2005; 40(8-9):685-93. PubMed ID: 16125352
[TBL] [Abstract][Full Text] [Related]
6. [Lighting effect on spontaneous tumor development in female rats].
Vinogradova IA; Bukalev AV; Zabezhinskiĭ MA; Semenchenko AV; Anisimov VN
Vopr Onkol; 2007; 53(5):554-61. PubMed ID: 18154120
[TBL] [Abstract][Full Text] [Related]
7. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
[TBL] [Abstract][Full Text] [Related]
8. Stressors and antistressors: how do they influence life span in HER-2/neu transgenic mice?
Semenchenko GV; Anisimov VN; Yashin AI
Exp Gerontol; 2004 Oct; 39(10):1499-511. PubMed ID: 15501020
[TBL] [Abstract][Full Text] [Related]
9. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
Jacquemart IC; Springs AE; Chen WY
Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.
Sas S; Chan T; Sami A; El-Gayed A; Xiang J
Cancer Gene Ther; 2008 Oct; 15(10):655-66. PubMed ID: 18421311
[TBL] [Abstract][Full Text] [Related]
11. Insulin in aging and cancer: antidiabetic drug Diabenol as geroprotector and anticarcinogen.
Popovich IG; Zabezhinski MA; Egormin PA; Tyndyk ML; Anikin IV; Spasov AA; Semenchenko AV; Yashin AI; Anisimov VN
Int J Biochem Cell Biol; 2005 May; 37(5):1117-29. PubMed ID: 15743682
[TBL] [Abstract][Full Text] [Related]
12. Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice.
Sakai Y; Morrison BJ; Burke JD; Park JM; Terabe M; Janik JE; Forni G; Berzofsky JA; Morris JC
Cancer Res; 2004 Nov; 64(21):8022-8. PubMed ID: 15520211
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of tumor regression and resistance to estrogen deprivation and fulvestrant in a model of estrogen receptor-positive, HER-2/neu-positive breast cancer.
Massarweh S; Osborne CK; Jiang S; Wakeling AE; Rimawi M; Mohsin SK; Hilsenbeck S; Schiff R
Cancer Res; 2006 Aug; 66(16):8266-73. PubMed ID: 16912207
[TBL] [Abstract][Full Text] [Related]
14. [The effect of SSH&H on the lifespan and spontaneous cancer development in transgenic mice with HER-2/neu mutation].
Tyndyk ML; Popovich IG; Anikin IV; Egormin PA; Iurova MN; Zabezhinskiĭ MA; Anisimov VN
Vopr Onkol; 2012; 58(2):243-7. PubMed ID: 22774532
[TBL] [Abstract][Full Text] [Related]
15. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
Pupa SM; Iezzi M; Di Carlo E; Invernizzi A; Cavallo F; Meazza R; Comes A; Ferrini S; Musiani P; Ménard S
Cancer Res; 2005 Feb; 65(3):1071-8. PubMed ID: 15705909
[TBL] [Abstract][Full Text] [Related]
17. HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination.
Chan T; Sami A; El-Gayed A; Guo X; Xiang J
Gene Ther; 2006 Oct; 13(19):1391-402. PubMed ID: 16724093
[TBL] [Abstract][Full Text] [Related]
18. Immunological prevention of a multigene cancer syndrome.
Croci S; Nicoletti G; Landuzzi L; De Giovanni C; Astolfi A; Marini C; Di Carlo E; Musiani P; Forni G; Nanni P; Lollini PL
Cancer Res; 2004 Nov; 64(22):8428-34. PubMed ID: 15548714
[TBL] [Abstract][Full Text] [Related]
19. Anti-HER-2/neu immune responses are induced before the development of clinical tumors but declined following tumorigenesis in HER-2/neu transgenic mice.
Takeuchi N; Hiraoka S; Zhou XY; Nagafuku M; Ono S; Tsujimura T; Nakazawa M; Yura Y; Hamaoka T; Fujiwara H
Cancer Res; 2004 Oct; 64(20):7588-95. PubMed ID: 15492286
[TBL] [Abstract][Full Text] [Related]
20. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
Masuelli L; Focaccetti C; Cereda V; Lista F; Vitolo D; Trono P; Gallo P; Amici A; Monaci P; Mattei M; Modesti M; Forni G; Kraus MH; Muraro R; Modesti A; Bei R
Int J Oncol; 2007 Feb; 30(2):381-92. PubMed ID: 17203220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
